Regarding the TNFα-mediated NF-κB pathway, the reduction of EZH2 hypothesized the participated effects of EZH2 on NF-κB signaling in enhancing inflammation in IBD patients90-92 (Figure 4). This evidence concerns the gene NFKB1 and inflammatory bowel disease.